Issue No 01+02/2005

Abstract

What Cardiologists do Need to Know about Procalcitonin

by Christian Mueller, Mirjam Christ-Crain, Beat Müller
Abstract

The Use of B-type Natriuretic Peptide in the Diagnosis of Acute Dyspnoea

by Christian Mueller, Kirsten Laule-Kilian, Andreas Christ, Daniel Staub
Abstract

Serum Hyaluronic Acid Levels are Elevated in Arthritis Patients, but Normal and Not Associated with Clinical Data in Patients with Fibromyalgia Syndrome

by Egon Werle, Hans-Peter Jäkel, Annette Müller, Heinrich Fischer, Walter Fiehn, Wolfgang Eich
Abstract

Evolution of the Parathyroid Hormone (PTH) Assay - Importance of Circulating PTH Immunoheterogeneity and of its Regulation

by Ping Gao and Pierre D'Amour
Abstract

The Abbott Architect c8000: Analytical Performance and Productivity Characteristics of a New Analyzer Applied to General Chemistry Testing

by Daniela Pauli, Michael Seyfarth, and Leif Dibbelt
Abstract

Clinical Significance of Hematocrit Interference in the Tacrolimus II Microparticle Enzyme Immunoassay: A Tentative Approach

by Jesús Hermida, M. Concepcion Fernändez, J. Carlos Tutor

Letter to the Editor: Sealing Ability of a Glass Ampoule

by Yutaka Tajima
Abstract

Evaluation of Alkaline Phosphatase Activity Assay for the Reflotron8 System after Substitution of the Comparison Method

by Ulrich Hübner, Gerhard Pape, Johannes Lotz, Thomas Bertsch, Manfred Kraft, Jürgen Geisel,and Wolfgang Herrmann
Abstract

Rationale for Testing the Cardiovascular Risk for Patients with COX-2 Inhibitors on the Basis of Biomarker NT-proBNP

by Evangelos Giannitsis
Abstract

Rationale zur Testung des kardiovaskulären Risikos bei Patienten mit COX-2-Hemmern anhand des Biomarkers NT-proBNP

by Evangelos Giannitsis